La. Seeks $12B In Avandia Medicaid Fraud Suit
In a suit seeking more than $12 billion in damages, Louisiana claims that its Medicaid program paid fraudulently inflated prices for GlaxoSmithKline PLC's diabetes treatment Avandia because the company concealed the...To view the full article, register now.
Already a subscriber? Click here to view full article